Invacare Corporation (NYSE:IVC) enjoyed a 109.51% run-up in share price since hitting record low of $3.05. The stock managed -4.63% fall and now stands at $6.39 as of 5/23/2019. At a recent session, the prices were hovering between $6.66 and $6.83. This company shares are 119.09% off its target price of $14 and the current market capitalization stands at $227.36M. The recent change has given its price a -16.39% deficit over SMA 50 and -68.05% deficit over its 52-week high. The stock witnessed -13.88% declines, -35.39% declines and 15.14% gains for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found IVC’s volatility during a week at 5.17% and during a month it has been found around 5.54%.Invacare Corporation (IVC) Top Holders
Institutional investors currently hold around $267 million or 0% in IVC stock. Look at its top three institutional owners: Blackrock Inc. owns $32.97 million in Invacare Corporation, which represents roughly 14.5% of the company’s market cap and approximately 12.35% of the institutional ownership. Similar statistics are true for the second largest owner, Elk Creek Partners, Llc, which owns 3,177,507 shares of the stock are valued at $21.29 million. The third largest holder is Dimensional Fund Advisors Lp, which currently holds $18.27 million worth of this stock and that ownership represents nearly 8.03% of its market capitalization.
At the end of March reporting period, 93 institutional holders increased their position in Invacare Corporation (NYSE:IVC) by some 7,328,795 shares, 65 decreased positions by 8,669,827 and 24 held positions by 23,790,280. That puts total institutional holdings at 39,788,902 shares, according to SEC filings. The stock grabbed 34 new institutional investments totaling 2,536,776 shares while 17 institutional investors sold out their entire positions totaling 1,453,812 shares.Invacare Corporation (NYSE:IVC) Insider Trades
Multiple company employees have indulged in significant insider trading. Invacare Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Senior VP and CFO Leneghan Kathleen P. has acquired 6,500 shares of Invacare Corporation (IVC) in the trading session dated Nov. 20, 2018. These shares are worth $35,880 and were traded at $5.52 each. The SEC filing shows that NASTAS CLIFFORD D performed a purchase of 9,000 shares. The Director added these shares by way of transaction on Nov. 19, 2018. The company’s shares were assimilated at $5.42 per share worth to an investment of some $48,780 to the account of NASTAS CLIFFORD D.
Chairman, President and CEO, Monaghan Matthew E., purchased 13,750 common shares of Invacare Corporation (IVC) in the open market. In a transaction dated Nov. 08, 2018, the shares were bought at an average price of $7.26, giving away a sum of $99,825. After this purchase, 243,897 common shares of IVC are directly owned by the insider, with total stake valued at $1,558,502.
In the transaction dated Jun. 29, 2018, a great number of shares sold came courtesy the SVP & GM, North America; Childers Dean J. disposed a total of 7,000 shares at an average price of $18.71, amounting to approximately $130,970. The insider now directly owns 35,221 shares worth $225,062.
Several analysts have released their opinion on Invacare Corporation (NYSE:IVC), with 1 analysts believing it is a strong buy. Whereas 2 of them predict the stock is a hold. Also, there are 2 buy, 0 sell and 0 strong sell ratings, collectively assigning a 2.2 average brokerage recommendation [T1].